pLenti-puro/RAF1 Citations (1)

Originally described in: CRAF mutations in lung cancer can be oncogenic and predict sensitivity to combined type II RAF and MEK inhibition.
Noeparast A, Giron P, Noor A, Bahadur Shahi R, De Brakeleer S, Eggermont C, Vandenplas H, Boeckx B, Lambrechts D, De Greve J, Teugels E Oncogene. 2019 Aug;38(31):5933-5941. doi: 10.1038/s41388-019-0866-7. Epub 2019 Jul 8. PubMed Journal

---

Articles Citing pLenti-puro/RAF1

Articles
Preservation of Human Colonic Stem Cells Requires an ERK Dynamics Checkpoint Mediated by AKT. Riede L, Borowiec A, Mallick S, Mallick S, Chakrabarti J, Thorne CA, Pond KW. bioRxiv [Preprint]. 2026 Apr 11:2026.04.02.715982. doi: 10.64898/2026.04.02.715982. PubMed

If you have published an article using this material, please email us at to have your article added to this page.